Higher-risk Myelodysplastic Syndromes Clinical Trials

7 clinical trials for Higher-risk Myelodysplastic Syndromes across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression — RECRUITING · PHASE1
• Study of REM-422 in Patients With AML or Higher Risk MDS — RECRUITING · PHASE1
• A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes — RECRUITING · PHASE2
• VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS — RECRUITING · PHASE1
• Prospective randomized study on the feasibility of allogeneic stem cell transplantation in higher-risk-myelodysplastic syndromes, performed upfront or preceded by azacitidine or conventional chemotherapy, according to the BM-blast proportion (ACROBAT trial). MDS0519 — TERMINATED · PHASE3
• Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes — NOT_YET_RECRUITING · PHASE2
• A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02) — TERMINATED · PHASE1

Refine this search